NO921364L - Hybridpolypeptid - Google Patents
HybridpolypeptidInfo
- Publication number
- NO921364L NO921364L NO92921364A NO921364A NO921364L NO 921364 L NO921364 L NO 921364L NO 92921364 A NO92921364 A NO 92921364A NO 921364 A NO921364 A NO 921364A NO 921364 L NO921364 L NO 921364L
- Authority
- NO
- Norway
- Prior art keywords
- polypeptide
- hybrid
- avidin
- interest
- high yield
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/675—Beta-endorphins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1018—Carboxy- and carbamoyl transferases (2.1.3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/687,819 US6072039A (en) | 1991-04-19 | 1991-04-19 | Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest |
Publications (2)
Publication Number | Publication Date |
---|---|
NO921364D0 NO921364D0 (no) | 1992-04-08 |
NO921364L true NO921364L (no) | 1992-10-20 |
Family
ID=24761988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92921364A NO921364L (no) | 1991-04-19 | 1992-04-08 | Hybridpolypeptid |
Country Status (13)
Country | Link |
---|---|
US (1) | US6072039A (fi) |
EP (1) | EP0511747A1 (fi) |
JP (1) | JPH06166698A (fi) |
KR (1) | KR920019820A (fi) |
AU (1) | AU659139B2 (fi) |
BR (1) | BR9201437A (fi) |
CA (1) | CA2064933A1 (fi) |
FI (1) | FI921740A (fi) |
IE (1) | IE921250A1 (fi) |
IL (1) | IL101454A0 (fi) |
MX (1) | MX9201749A (fi) |
NO (1) | NO921364L (fi) |
NZ (1) | NZ242395A (fi) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5541087A (en) * | 1994-09-14 | 1996-07-30 | Fuji Immunopharmaceuticals Corporation | Expression and export technology of proteins as immunofusins |
WO1996021156A1 (en) * | 1995-01-04 | 1996-07-11 | Abbott Laboratories | Method for preparing scintillation proximity assay targets |
AU763719B2 (en) | 1997-12-08 | 2003-07-31 | Merck Patent Gmbh | Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
EP0985931A3 (en) * | 1998-09-04 | 2000-03-29 | Becton Dickinson and Company | Recombinant antigen immunoassay for the diagnosis of syphilis |
US20040009535A1 (en) | 1998-11-27 | 2004-01-15 | Celltech R&D, Inc. | Compositions and methods for increasing bone mineralization |
SK782002A3 (en) | 1999-07-21 | 2003-08-05 | Lexigen Pharm Corp | FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
CA2380331C (en) | 1999-08-09 | 2012-11-20 | Lexigen Pharmaceuticals Corp. | Multiple cytokine-antibody complexes |
DE19952956A1 (de) | 1999-11-03 | 2001-05-17 | Acgt Progenomics Ag | Verfahren zur Verbindung von molekularen Substanzen |
CA2399832C (en) | 2000-02-11 | 2011-09-20 | Stephen D. Gillies | Enhancing the circulating half-life of antibody-based fusion proteins |
US20020142355A1 (en) * | 2000-11-14 | 2002-10-03 | Baylor College Of Medicine | Methods for the in vivo biotin labeling of polypeptides |
KR20090010127A (ko) | 2001-03-07 | 2009-01-28 | 메르크 파텐트 게엠베하 | 하이브리드 이소타입 항체 부분구조를 포함하는 단백질을 위한 발현 기술 |
WO2002079415A2 (en) | 2001-03-30 | 2002-10-10 | Lexigen Pharmaceuticals Corp. | Reducing the immunogenicity of fusion proteins |
DE60239454D1 (de) | 2001-05-03 | 2011-04-28 | Merck Patent Gmbh | Rekombinanter, tumorspezifischer antikörper und dessen verwendung |
US7270960B2 (en) | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
PT1454138E (pt) | 2001-12-04 | 2012-03-28 | Merck Patent Gmbh | Imunocitoquinas com seletividade modulada |
AU2002363961A1 (en) * | 2001-12-05 | 2003-06-23 | Kentucky Bioprocessing, Llc | Flexible method and apparatus for high throughput production and purification of multiple proteins |
GB0202018D0 (en) * | 2002-01-29 | 2002-03-13 | Sense Proteomic Ltd | Tag and method |
US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
RU2366664C2 (ru) | 2002-12-17 | 2009-09-10 | Мерк Патент Гмбх | Гуманизированное антитело (н14.18) на основании антитела 14.18 мыши, связывающееся с gd2, и его слияние с il-2 |
EP1636270B1 (en) | 2003-06-16 | 2016-07-20 | UCB Pharma S.A. | Antibodies specific for sclerostin and methods for increasing bone mineralization |
EP1699822B1 (en) | 2003-12-30 | 2008-04-23 | MERCK PATENT GmbH | Il-7 fusion proteins with antibody portions, their preparation and their use |
AU2005206277B2 (en) | 2004-01-22 | 2011-06-23 | Merck Patent Gmbh | Anti-cancer antibodies with reduced complement fixation |
US7670595B2 (en) | 2004-06-28 | 2010-03-02 | Merck Patent Gmbh | Fc-interferon-beta fusion proteins |
DE102005040347A1 (de) | 2005-08-25 | 2007-03-01 | Profos Ag | Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von Listerien |
PT1966245E (pt) | 2005-12-30 | 2011-08-31 | Merck Patent Gmbh | Anticorpos anti-cd19 com imunogenicidade reduzida |
ES2384055T3 (es) | 2005-12-30 | 2012-06-28 | Merck Patent Gmbh | Variantes de la interleucina-12p40 con estabilidad mejorada |
JP2009529917A (ja) | 2006-03-22 | 2009-08-27 | ヴァイラル ロジック システムズ テクノロジー コーポレーション | 標的ポリペプチドの同定方法および免疫学的疾患の治療のためのその使用 |
US8377448B2 (en) | 2006-05-15 | 2013-02-19 | The Board Of Trustees Of The Leland Standford Junior University | CD47 related compositions and methods for treating immunological diseases and disorders |
US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
EP3753947A1 (en) | 2007-09-14 | 2020-12-23 | Adimab, LLC | Rationally designed, synthetic antibody libraries and uses therefor |
JP5781501B2 (ja) | 2009-04-22 | 2015-09-24 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | 改変されたFcRn結合部位を有する抗体融合タンパク質 |
EP2527431A1 (en) | 2011-05-26 | 2012-11-28 | bioMérieux S.A. | Novel Listeria bacteriophage tailspike protein and uses thereof |
US20150099860A1 (en) * | 2013-10-08 | 2015-04-09 | Proteins Easy Corp | Methods for separating and purifying endogenous, exogenous and recombinant proteins/peptides from plants and animals using aqueous-free, anhydrous strategies |
CN106156530A (zh) * | 2016-08-03 | 2016-11-23 | 北京好运到信息科技有限公司 | 基于栈式自编码器的体检数据分析方法及装置 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839293A (en) * | 1986-02-24 | 1989-06-13 | The Trustees Of Columbia University In The City Of New York | DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof |
PT89121A (pt) * | 1987-12-04 | 1989-12-29 | Du Pont | Processo para a preparacao de interleuquina-2 imobilizada e interleuquina-2 contendo uma extensao no terminal-carboxilo com actividade de interleuquina-2 natural |
AU3342689A (en) * | 1988-03-24 | 1989-10-16 | Igen Incorporated | Luminescent chimeric proteins |
CA2057908A1 (en) * | 1989-05-19 | 1990-11-20 | John E. Cronan, Jr. | Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
EP0711303B2 (en) * | 1993-07-30 | 2009-06-10 | Affymax, Inc. | Biotinylation of proteins |
-
1991
- 1991-04-19 US US07/687,819 patent/US6072039A/en not_active Expired - Lifetime
-
1992
- 1992-04-02 AU AU13987/92A patent/AU659139B2/en not_active Ceased
- 1992-04-02 IL IL101454A patent/IL101454A0/xx unknown
- 1992-04-02 CA CA002064933A patent/CA2064933A1/en not_active Abandoned
- 1992-04-07 EP EP92303067A patent/EP0511747A1/en not_active Withdrawn
- 1992-04-08 NO NO92921364A patent/NO921364L/no unknown
- 1992-04-14 MX MX9201749A patent/MX9201749A/es unknown
- 1992-04-16 IE IE125092A patent/IE921250A1/en not_active Application Discontinuation
- 1992-04-16 BR BR929201437A patent/BR9201437A/pt not_active Application Discontinuation
- 1992-04-16 FI FI921740A patent/FI921740A/fi unknown
- 1992-04-16 NZ NZ242395A patent/NZ242395A/xx unknown
- 1992-04-17 JP JP4098307A patent/JPH06166698A/ja not_active Withdrawn
- 1992-04-18 KR KR1019920006525A patent/KR920019820A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU1398792A (en) | 1992-10-22 |
FI921740A (fi) | 1992-10-20 |
EP0511747A1 (en) | 1992-11-04 |
NO921364D0 (no) | 1992-04-08 |
KR920019820A (ko) | 1992-11-20 |
MX9201749A (es) | 1992-10-01 |
US6072039A (en) | 2000-06-06 |
IE921250A1 (en) | 1992-10-21 |
AU659139B2 (en) | 1995-05-11 |
NZ242395A (en) | 1993-12-23 |
BR9201437A (pt) | 1992-12-01 |
CA2064933A1 (en) | 1992-10-20 |
IL101454A0 (en) | 1992-12-30 |
FI921740A0 (fi) | 1992-04-16 |
JPH06166698A (ja) | 1994-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO921364L (no) | Hybridpolypeptid | |
AU3676595A (en) | Expression and export technology of proteins as immunofusins | |
EP0824148A3 (en) | Polyester synthase gene and process for producing polyester | |
BG101408A (en) | Analogs of keratinocyte growth factor | |
KR920004419A (ko) | 신규 폴리펩티드 및 이를 유효성분으로 하는 의약조성물 | |
ES2183960T3 (es) | ,cj2, una cisteimproteasa apoptotica, y composiciones para producirla y metodos de utilizacion. | |
Lai | Studies on the structure of rabbit muscle aldolase: Determination of the primary structure of the COOH-terminal BrCN peptide; the complete sequence of the subunit polypeptide chain | |
KR870004139A (ko) | 인체 λ-인터페론의 생물학적 활성 유도체를 제조하는 방법 | |
AU583388B2 (en) | High performance liquid chromatography mobile phase | |
EA200000202A1 (ru) | Рекомбинантная экспрессия c-пептида инсулина | |
ATE79409T1 (de) | Herstellungsverfahren fuer humanes atriales natriuretisches polypeptid. | |
CA2342072A1 (en) | Kunitz domain polypeptide zkun6 | |
DE60029791D1 (de) | Rezeptor eines neurotrophen faktors (gfr-alpha-4) | |
HUT69979A (en) | Method for producing protein c | |
AU1093597A (en) | Vector for expression of n-terminally extended proteins in yeast cell | |
UY24112A1 (es) | Proceso para purificar antigeno viral de superficie de hepatitis b incluyendo el peptido pres 2 | |
PT101065A (pt) | Sequencias de adn e vectores que codificam carminomicina-4-0-metil-transferase e processo para a preparacao de daunorrubicina | |
Qureshi et al. | The isolation of acyl carrier protein from the pigeon liver fatty acid synthetase complex II | |
KR860008283A (ko) | 인체 췌장 엘라스타제의 제조방법 | |
GB2073204A (en) | Process for producing an insulin precursor | |
IE810114L (en) | N-benzyloxycarbonyl-l-aspartic acid | |
JPS5783283A (en) | Novel yeast | |
JPS5299282A (en) | Preparation of yeast cells | |
EP0571337A3 (en) | Process to purify proteins from cell systems | |
Khai et al. | Glutamic oxaloacetic transaminase isozymes from rat liver. Purification and physicochemical characterization.: Purification and Physicochemical Characterization |